Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ·Healthcare·Biotechnology
$2.30
-13.21%
Mkt Cap $163.55M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+204.3%
Consensus $7.00 vs current $2.30
NASDAQ·Healthcare·Biotechnology
$2.30
-13.21%
Mkt Cap $163.55M
No recent rating data.
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
+204.3%
Consensus $7.00 vs current $2.30